METHOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS
US Application 16/132,852
Filed on 2018-09-17
Filed on 2018-09-17
11-OXO-10,11-Dihydrodibenzo[B,F][1,4]Thiazepine S-Oxide Derivatives And Their Use As Dopamine D2 Receptor Antagonists
Ireland
14750663.8
Filed on 2016-01-22
14750663.8
Filed on 2016-01-22
11-OXO-10,11-Dihydrodibenzo[B,F][1,4]Thiazepine S-Oxide Derivatives And Their Use As Dopamine D2 Receptor Antagonists
United Kingdom
14750663.8
Filed on 2016-01-22
14750663.8
Filed on 2016-01-22
11-OXO-10,11-Dihydrodibenzo[B,F][1,4]Thiazepine S-Oxide Derivatives And Their Use As Dopamine D2 Receptor Antagonists
France
14750663.8
Filed on 2016-01-22
14750663.8
Filed on 2016-01-22
11-OXO-10,11-Dihydrodibenzo[B,F][1,4]Thiazepine S-Oxide Derivatives And Their Use As Dopamine D2 Receptor Antagonists
Germany
14750663.8
Filed on 2016-01-22
14750663.8
Filed on 2016-01-22
11-OXO-10,11-Dihydrodibenzo[B,F][1,4]Thiazepine S-Oxide Derivatives And Their Use As Dopamine D2 Receptor Antagonists
Switzerland
14750663.8
Filed on 2016-01-22
14750663.8
Filed on 2016-01-22
11-OXO-10,11-Dihydrodibenzo[B,F][1,4]Thiazepine S-Oxide Derivatives And Their Use As Dopamine D2 Receptor Antagonists
Belgium
14750663.8
Filed on 2016-01-22
14750663.8
Filed on 2016-01-22
SELECTIVE D3 DOPAMINE RECEPTOR AGONISTS AND METHODS OF THEIR USE
US Patent 11,634,404
Filed on 2018-10-12
Filed on 2018-10-12
Selective D3 Dopamine Receptor Agonists and Methods of Their Use
European Patent
17733098.2
Filed on 2018-10-23
17733098.2
Filed on 2018-10-23